2026 Another Catalyst Rich Year: AstraZeneca CFO
Aradhana Sarin, AstraZeneca CFO, joins Dani Burger and Katie Greifeld on "Bloomberg Deals." AstraZeneca’s profit grew more than expected in the first quarter, bolstered by demand for its blockbuster cancer medicines. (Source: Bloomberg)
AstraZeneca beats expectations
- UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies CNBC —
- Astrazeneca tops expectations in the first quarter on strong cancer drug sales Associated Press —
- AstraZeneca posted stronger-than-expected profit and revenue on surging cancer drug sales Quartz —
- AstraZeneca makes surprise U-turn with £300m pharma investment The Guardian —
- Shot in the arm for GSK and AstraZeneca from cancer drug sales The Argus —